Used in pharmaceutical research as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly those targeting vascular endothelial growth factor receptors (VEGFR). Its structure supports activity in anti-angiogenic compounds, making it valuable in developing anticancer agents. Also explored in the design of small-molecule inhibitors for targeted cancer therapies due to its ability to enhance solubility and binding affinity.